Mu-Yan Cai

3.8k total citations
58 papers, 2.9k citations indexed

About

Mu-Yan Cai is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Mu-Yan Cai has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Surgery and 19 papers in Oncology. Recurrent topics in Mu-Yan Cai's work include Epigenetics and DNA Methylation (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Mu-Yan Cai is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer-related molecular mechanisms research (6 papers). Mu-Yan Cai collaborates with scholars based in China, Hong Kong and United States. Mu-Yan Cai's co-authors include Dan Xie, Xin‐Yuan Guan, Yi-Xin Zeng, Hsiang‐Fu Kung, Jie-Wei Chen, Yiji Liao, Rong-Zhen Luo, Marie C. Lin, Xiu‐Wu Bian and Jing‐Ping Yun and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mu-Yan Cai

58 papers receiving 2.8k citations

Peers

Mu-Yan Cai

ONCOL

PRM

SURGE

Gregor Krings United States

Midie Xu China

Seung Myung Dong South Korea

Chang Han United States

Shiu‐Feng Huang Taiwan

Umesh Bhanot United States

Shigetsugu Takano Japan

Yoshihiko Kitajima Japan

Susumu Saigusa Japan

Gianmarco Contino Italy

Gregor Krings United States

Mu-Yan Cai

1.2k ×0.7

813 ×0.8

825 ×1.1

ONCOL

438 ×0.9

PRM

464 ×1.0

SURGE

Citations per year, relative to Mu-Yan Cai Mu-Yan Cai (= 1×) peers Gregor Krings

Countries citing papers authored by Mu-Yan Cai

Since Specialization

Citations

This map shows the geographic impact of Mu-Yan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Yan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Yan Cai more than expected).

Fields of papers citing papers by Mu-Yan Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu-Yan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Yan Cai. The network helps show where Mu-Yan Cai may publish in the future.

Co-authorship network of co-authors of Mu-Yan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Mu-Yan Cai. A scholar is included among the top collaborators of Mu-Yan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu-Yan Cai. Mu-Yan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xin, Jiaxing Zhang, Junhang Luo, et al.. (2018). CSTF2-Induced Shortening of the RAC1 3′UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. Cancer Research. 78(20). 5848–5862. 55 indexed citations

Wang, Feng-Wei, Chenhui Cao, Kai Han, et al.. (2018). APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. Journal of Clinical Investigation. 129(2). 727–743. 131 indexed citations

Cai, Mu-Yan, Feng-Wei Wang, Chang-Peng Li, et al.. (2016). Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chinese Journal of Cancer. 35(1). 80–80. 14 indexed citations

Liu, Shi-Liang, Simone Anfossi, Bo Qiu, et al.. (2016). Prognostic Factors for Locoregional Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma Treated with Radical Two-Field Lymph Node Dissection: Results from Long-Term Follow-Up. Annals of Surgical Oncology. 24(4). 966–973. 19 indexed citations

Zhang, Xin-Ke, Zhi-Ling Zhang, Xu Lu, et al.. (2016). Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma. Clinical Genitourinary Cancer. 14(4). 341–345.e3. 16 indexed citations

Zhang, Xin-Ke, Miao Xu, Jie-Wei Chen, et al.. (2015). The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma. Tumor Biology. 36(7). 5201–5208. 9 indexed citations

Li, Ning, Miao Xu, Mu-Yan Cai, et al.. (2015). Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer. Cancer Epidemiology. 39(5). 763–768. 29 indexed citations

Zheng, Fang, Yiji Liao, Mu-Yan Cai, et al.. (2015). Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets. PLoS Genetics. 11(2). e1004873–e1004873. 86 indexed citations

Li, Peng, Yi-Hong Ling, Xin-Ke Zhang, et al.. (2015). The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer. 15(1). 370–370. 52 indexed citations

10.

Qiu, Miao‐Zhen, Mu-Yan Cai, Dong-sheng Zhang, et al.. (2013). Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. Journal of Translational Medicine. 11(1). 58–58. 129 indexed citations

11.

Lin, Huan-Xin, Hui-Juan Qiu, Hui-Lan Rao, et al.. (2013). Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma. PLoS ONE. 8(4). e60516–e60516. 47 indexed citations

12.

Zhou, Juan, Mu-Yan Cai, Yi-Ji Liao, et al.. (2012). CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival. BMC Cancer. 12(1). 437–437. 40 indexed citations

13.

Cai, Mu-Yan, Guo-Liang Xu, Xiao Hai Li, et al.. (2012). Prognostic Significance of Overexpression of EZH2 and H3k27me3 Proteins in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 13(7). 3173–3178. 68 indexed citations

14.

Cai, Mu-Yan, Rong-Zhen Luo, Jie-Wei Chen, et al.. (2012). Overexpression of ZEB2 in Peritumoral Liver Tissue Correlates with Favorable Survival after Curative Resection of Hepatocellular Carcinoma. PLoS ONE. 7(2). e32838–e32838. 34 indexed citations

15.

Zhao, Lei, Li-Ru He, Mian Xi, et al.. (2012). Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3. Journal of Translational Medicine. 10(1). 249–249. 36 indexed citations

16.

Huang, Yan, Chun Yi, Li-Li Liu, et al.. (2012). Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis. Journal of Translational Medicine. 10(1). 106–106. 34 indexed citations

17.

Liu, Xue-Wen, Chuan-Miao Xie, Hui Li, et al.. (2011). Nasopharyngeal adenoid cystic carcinoma: magnetic resonance imaging features in ten cases. Chinese Journal of Cancer. 32(5). 19–28. 8 indexed citations

18.

Cai, Mu-Yan, Jie-Wei Chen, Xin‐Yuan Guan, et al.. (2011). High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis. Chinese Journal of Cancer Research. 23(3). 201–207. 62 indexed citations

19.

Luo, Rong-Zhen, Jie-Wei Chen, Yun Cao, et al.. (2011). High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma. Journal of Translational Medicine. 9(1). 5–5. 93 indexed citations

20.

Cai, Mu-Yan, Li-Ru He, Shi-Juan Mai, et al.. (2010). EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients. Carcinogenesis. 31(9). 1576–1583. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact